{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:42:22Z","timestamp":1784698942215,"version":"3.55.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["23790516"],"award-info":[{"award-number":["23790516"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006398","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T17:23:48Z","timestamp":1523899428000},"page":"e0006398","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-4165","authenticated-orcid":true,"given":"Mutsuyo","family":"Takayama-Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Kweng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Posadas-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itoe","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Taimur","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinjiro","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4149\/av_2013_02_160","article-title":"Lymphocytic choriomeningitis virus: invisible but not innocent","volume":"57","author":"K Lapo\u0161ov\u00e1","year":"2013","journal-title":"Acta Virol"},{"issue":"3","key":"ref2","first-page":"159","article-title":"Arenaviruses: protein structure and function","volume":"262","author":"MJ Buchmeier","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref3","first-page":"1","article-title":"Molecular phylogeny of the arenaviruses","volume":"262","author":"JCS Clegg","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"21","key":"ref4","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa053240","article-title":"Transmission of Lymphocytic Choriomeningitis Virus by Organ Transplantation","volume":"354","author":"SA Fischer","year":"2006","journal-title":"N Engl J Med"},{"issue":"21","key":"ref5","first-page":"537","article-title":"Lymphocytic choriomeningitis virus infection in organ transplant recipients\u2014Massachusetts, Rhode Island, 2005","volume":"54","year":"2005","journal-title":"MMWR"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1067\/mob.2002.126297","article-title":"Lymphocytic choriomeningitis virus: Emerging fetal teratogen","volume":"187","author":"LL Barton","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.ajog.2005.11.040","article-title":"Lymphocytic choriomeningitis virus: An emerging obstetric pathogen?","volume":"194","author":"DJ Jamieson","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890370102","article-title":"Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys","volume":"37","author":"JB McCormick","year":"1992","journal-title":"J Med Virol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jmv.1890290312","article-title":"Formalin inactivated junin virus: Immunogenicity and protection assays","volume":"29","author":"C Videla","year":"1989","journal-title":"J Med Virol"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4161\/hv.7.6.15198","article-title":"Argentine hemorrhagic fever vaccines","volume":"7","author":"A Ambrosio","year":"2011","journal-title":"Hum Vaccin"},{"issue":"2\u20133","key":"ref11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-1702(88)90033-0","article-title":"Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection","volume":"9","author":"DD Auperin","year":"1988","journal-title":"Virus Res"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0042-6822(89)90525-4","article-title":"Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus","volume":"171","author":"HG Morrison","year":"1989","journal-title":"Virology"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1073\/pnas.86.1.317","article-title":"Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene","volume":"86","author":"SP Fisher-Hoch","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for lassa fever","volume":"74","author":"SP Fisher-Hoch","year":"2000","journal-title":"J Virol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003736","article-title":"A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses","volume":"9","author":"D Safronetz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"TW Geisbert","year":"2005","journal-title":"PLoS Med"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1743-422X-7-279","article-title":"Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever","volume":"7","author":"LM Branco","year":"2010","journal-title":"Virol J"},{"issue":"1\u20132","key":"ref18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virusres.2011.09.005","article-title":"Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses","volume":"162","author":"RJ Grant-Klein","year":"2011","journal-title":"Virus Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0042-6822(90)90336-P","article-title":"Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope","volume":"178","author":"LS Klavinskis","year":"1990","journal-title":"Virology"},{"issue":"39","key":"ref20","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1016\/j.vaccine.2010.12.064","article-title":"A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge","volume":"29","author":"DJ Shedlock","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/JVI.69.4.2684-2688.1995","article-title":"DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection","volume":"69","author":"M Yokoyama","year":"1995","journal-title":"J Virol"},{"issue":"14","key":"ref22","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1073\/pnas.94.14.7503","article-title":"Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells","volume":"94","author":"C Sedlik","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virol.2016.11.001","article-title":"Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein","volume":"501","author":"BYH Cheng","year":"2017","journal-title":"Virology"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14760584.2016.1184575","article-title":"Vaccine platforms to control Lassa fever","volume":"15","author":"IS Lukashevich","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"ref25","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"DL Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1073\/pnas.83.11.3914","article-title":"Walking along the rabies genome: is the large G-L intergenic region a remnant gene?","volume":"83","author":"N Tordo","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"ref27","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"MJ Schnell","year":"1994","journal-title":"EMBO J"},{"issue":"14","key":"ref28","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1073\/pnas.93.14.7310","article-title":"Highly stable expression of a foreign gene from rabies virus vectors","volume":"93","author":"T Mebatsion","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref29","article-title":"Advances in virus research","volume":"79","author":"EA Gomme","year":"2011"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1348-0421.2005.tb03692.x","article-title":"Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain","volume":"49","author":"N Ito","year":"2005","journal-title":"Microbiol Immunol"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/605949","article-title":"Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates","volume":"200","author":"J Cenna","year":"2009","journal-title":"J Infect Dis"},{"issue":"16","key":"ref32","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1128\/JVI.00800-13","article-title":"B Cell Infection and Activation by Rabies Virus-Based Vaccines","volume":"87","author":"AG Lytle","year":"2013","journal-title":"J Virol"},{"issue":"15","key":"ref33","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.vaccine.2014.01.043","article-title":"Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs","volume":"32","author":"JP McGettigan","year":"2014","journal-title":"Vaccine"},{"key":"ref34","first-page":"1126","article-title":"A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses","volume":"2015","author":"A Dunkel","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virol.2012.07.020","article-title":"A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence","volume":"434","author":"AB Papaneri","year":"2012","journal-title":"Virology"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003389","article-title":"Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine","volume":"9","author":"JE Blaney","year":"2013","journal-title":"PLoS Pathog"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.virol.2003.10.001","article-title":"Generation and characterization of P gene-deficient rabies virus","volume":"318","author":"Y Shoji","year":"2004","journal-title":"Virology"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2005.03.011","article-title":"Characterization of P gene-deficient rabies virus: Propagation, pathogenicity and antigenicity","volume":"111","author":"K Morimoto","year":"2005","journal-title":"Virus Res"},{"issue":"1","key":"ref39","first-page":"94","article-title":"Studies on chick-embryo-adapted-rabies virus. VI. Further changes in pathogenic properties following prolonged cultivation in the developing chick embryo","volume":"72","author":"H Koprowski","year":"1954","journal-title":"J Immunol"},{"issue":"50","key":"ref40","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/j.vaccine.2008.08.069","article-title":"Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene","volume":"26","author":"J Cenna","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1348-0421.1999.tb02402.x","article-title":"Intracellular behavior of rabies virus matrix protein (M) is determined by the viral glycoprotein (G)","volume":"43","author":"K Nakahara","year":"1999","journal-title":"Microbiol Immunol"},{"key":"ref42","article-title":"Advances in virus research","volume":"79","author":"M Rieder","year":"2011"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2008.09.019","article-title":"Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity","volume":"382","author":"EJ Faul","year":"2008","journal-title":"Virology"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002352","article-title":"Type 1 interferons and antiviral CD8 T-Cell responses","volume":"8","author":"RM Welsh","year":"2012","journal-title":"PLoS Pathog"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0166-0934(02)00249-5","article-title":"An improved method for recovering rabies virus from cloned cDNA","volume":"107","author":"K Inoue","year":"2003","journal-title":"J Virol Methods"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1348-0421.2006.tb03829.x","article-title":"Possible mechanism of adenovirus generation from a cloned viral genome tagged with nucleotides at its ends","volume":"50","author":"H Fukuda","year":"2006","journal-title":"Microbiol Immunol"},{"key":"ref47","first-page":"114","article-title":"Lab Tech rabies","author":"AA King","year":"1996"},{"key":"ref48","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc15a01s8","article-title":"Lymphocytic Choriomeningitis Virus (LCMV): Propagation, Quantitation, and Storage","author":"RM Welsh","year":"2008","journal-title":"Curr Protoc Microbiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7883\/yoken1952.47.157","article-title":"A simple and efficient method for purification of infectious recombinant adenovirus","volume":"47","author":"Y Kanegae","year":"1994","journal-title":"Japanese J Med Sci Biol"},{"key":"ref50","first-page":"4434","article-title":"E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer","volume":"63","author":"K Fukuda","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0042-6822(83)90135-6","article-title":"Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization","volume":"130","author":"M Bruns","year":"1983","journal-title":"Virology"},{"issue":"1\u20132","key":"ref52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates","volume":"33","author":"M Battegay","year":"1991","journal-title":"J Virol Methods"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-1702(97)00080-4","article-title":"A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope","volume":"51","author":"TR Luo","year":"1997","journal-title":"Virus Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/JVI.02058-12","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"P Penaloza-MacMaster","year":"2013","journal-title":"J Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/eji.1830190302","article-title":"Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein","volume":"19","author":"M Hany","year":"1989","journal-title":"Eur J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1128\/JVI.68.6.3486-3490.1994","article-title":"Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized","volume":"68","author":"M Castrucci","year":"1994","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI200422374","article-title":"Kinetics of protective antibodies are determined by the viral surface antigen","volume":"114","author":"DD Pinschewer","year":"2004","journal-title":"J Clin Invest"},{"issue":"10","key":"ref58","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.4049\/jimmunol.151.10.5408","article-title":"Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells","volume":"151","author":"M Battegay","year":"1993","journal-title":"J Immunol"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa Fever","volume":"314","author":"JB McCormick","year":"1986","journal-title":"N Engl J Med"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.1890120203","article-title":"Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin","volume":"12","author":"PB Jahrling","year":"1983","journal-title":"J Med Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1128\/JVI.00955-07","article-title":"Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus","volume":"81","author":"B Eschli","year":"2007","journal-title":"J Virol"},{"issue":"43","key":"ref62","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1016\/j.vaccine.2012.07.073","article-title":"Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein","volume":"30","author":"AB Papaneri","year":"2012","journal-title":"Vaccine"},{"key":"ref63","unstructured":"World Health Organization. General manufacturing recommendations. In: WHO technical report series No 941. Geneva; 2007."},{"key":"ref64","unstructured":"World Health Organization. WHO Expert Consultation on rabies. In: WHO technical report series No 982. Geneva; 2013"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T04:16:41Z","timestamp":1693628201000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006398"}},"subtitle":[],"editor":[{"given":"Charles E.","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006398","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]}}}